The notices it replaced
3 notices since 2019, oldest first, each with its awards since FY2014.
- Posted 2019RFA-CA-19-0395 awards
- Posted 2020RFA-CA-20-0086 awards
- Posted 2020RFA-CA-21-0146 awards
- Posted 2022RFA-CA-22-022This notice, closed · 6 awards
Replaced by RFA-CA-23-015.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 23
- 23 new
- Median first-year cost
- $402,077
- $9,325,103 in all
- Institutions
- 20
- 23 contact PIs
- Patents
- 6
- from 1 funded project
Awards by fiscal year
0
0
0
0
0
0
5
6
6
6
0
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- JOHNS HOPKINS UNIVERSITY3
- UNIVERSITY OF PENNSYLVANIA2
- AUBURN UNIVERSITY AT AUBURN1
- BOSTON UNIVERSITY MEDICAL CAMPUS1
- CASE WESTERN RESERVE UNIVERSITY1
and 15 other institutions
Most frequent study sections
- Special Emphasis Panel (ZCA1 TCRB-T (J1))5
- Special Emphasis Panel (ZCA1 RTRB-R (M3))4
- Special Emphasis Panel (ZCA1 SRB-X (J1))4
- Special Emphasis Panel (ZCA1 TCRB-5 (J2))3
- Special Emphasis Panel (ZCA1 TCRB-J (M2))3
and 2 other study sections
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2023 | Visual Analytics for Exploration and Hypothesis Generation Using Highly MultiplexedSpatial Data of Tissues and Tumors1U01CA284207-01 | Pfister, HanspeterSantagata, Sandro | HARVARD MEDICAL SCHOOL, MA | First-year cost $415,436 | Study section ZCA1 |
| FY2023 | Robust privacy preserving distributed analysis platform for cancer research: addressing data bias and disparities1U01CA274576-01A1 | Jiang, XiaoqianLong, Qi | UNIVERSITY OF PENNSYLVANIA, PA | First-year cost $411,901 | Study section ZCA1 |
| FY2023 | m6A-suite: an informatics pipeline and resource for elucidating roles of m6A epitranscriptome in cancer1U01CA279618-01 | Huang, Yufei | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | First-year cost $408,557 | Study section ZCA1 |
| FY2023 | Matching genotypes with personalized therapies: Development of a decision support infrastructure to augment the value of precision medicine1U01CA274631-01A1 | Anagnostou, ValsamoBotsis, Taxiarchis | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $407,738 | Study section ZCA1 |
| FY2023 | Inferring Kinase Activity from Tumor Phosphoproteomic Data1U01CA284193-01 | Naegle, Kristen M | UNIVERSITY OF VIRGINIA, VA | First-year cost $404,886 | Study section ZCA1 |
| FY2023 | Personalization of graphical models using multi-omics data for subtype discovery and prognosis1U01CA274573-01A1 | Luu, Hung NNguyen, Tin C | AUBURN UNIVERSITY AT AUBURN, AL | First-year cost $392,740 | Study section ZCA1 |
| FY2022 | GEARBOx - a multisite clinical trial matching tool for children with relapsed or refractory cancer1U01CA269420-01 · under RFA-CA-21-014 | Volchenboum, Samuel | UNIVERSITY OF CHICAGO, IL | First-year cost $531,117 | Study section ZCA1 |
| FY2022 | Analytical tools for studying the tumor microenvironment leveraging spatial transcriptomics1U01CA274489-01 · under RFA-CA-21-014 | Fridley, Brooke L | H. LEE MOFFITT CANCER CTR & RES INST, FL | First-year cost $415,728 | Study section ZCA1 |
| FY2022 | muMS2: an open source R package for analyzing and integrating multi-omics datasets to improve early detection and understanding of colorectal cancer1U01CA264071-01A1 · under RFA-CA-21-014 | Balunas, Marcy JSchloss, Patrick David | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | First-year cost $408,122 | Study section ZCA1 |
| FY2022 | Developing informatics tools for optimized MRS for brain cancer research1U01CA269110-01 · under RFA-CA-21-014 | Marjanska, Malgorzata | UNIVERSITY OF MINNESOTA, MN | First-year cost $380,671 | Study section ZCA1 |
| FY2022 | A data-driven bioinformatics platform for the design and analysis of multiplexed antibody-based cytometry experiments in cancer research1U01CA269409-01A1 · under RFA-CA-21-014 | Gonzalez Camara, Pablo | UNIVERSITY OF PENNSYLVANIA, PA | First-year cost $359,378 | Study section ZCA1 |
| FY2022 | Development of Small Area Interactive Risk Maps for Cancer Control Efforts1U01CA258400-01A1 · under RFA-CA-21-014 | Oleson, Jacob | UNIVERSITY OF IOWA, IA | First-year cost $349,606 | Study section ZCA1 |
| FY2021 | Advanced development of Lancet, an emerging tool for complex variant calling in cancer genomics1U01CA253405-01A1 · under RFA-CA-20-008 | Narzisi, Giuseppe | NEW YORK GENOME CENTER, NY | First-year cost $506,507 | Study section ZCA1 |
| FY2021 | Informatics Tools To Analyze And Model Whole Slide Image Data At The Single Cell Level1U01CA249245-01A1 · under RFA-CA-20-008 | Xiao, Guanghua | UT SOUTHWESTERN MEDICAL CENTER, TX | First-year cost $407,930 | Study section ZCA1 |
| FY2021 | PROTEAN-CR: Proteomics Toolkit for Ensemble Analysis in Cancer Research1U01CA258512-01 · under RFA-CA-20-008 | Kavraki, Lydia E.Lizee, Gregory A | RICE UNIVERSITY, TX | First-year cost $402,077 | Study section ZCA1 |
| FY2021 | Utilizing Bayesian modeling to improve mutational signature inference in large-scale datasets1U01CA253500-01A1 · under RFA-CA-20-008 | Campbell, Joshua DYajima, Masanao | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | First-year cost $401,917 | Study section ZCA1 |
| FY2021 | An informatics bridge over the valley of death for cancer Phase I trials of drug-combination therapies1U01CA248240-01A1 · under RFA-CA-20-008 | Li, Lang | OHIO STATE UNIVERSITY, OH | First-year cost $387,617 | Study section ZCA1 |
| FY2021 | Integrative genomic and epigenomic analysis of cancer using long read sequencing1U01CA253481-01A1 · under RFA-CA-20-008 | Schatz, Michael | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $383,463 | Study section ZCA1 |
| FY2020 | Single-cell and imaging data integration software to spatially resolve the tumor microenvironment1U01CA253403-01 · under RFA-CA-19-039 | Fertig, Elana | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $405,874 | Study section ZCA1 |
| FY2020 | Informatics for Functional Integration of Heterogeneous Cancer Genome and Transcriptome Sequencing Data1U01CA247760-01 · under RFA-CA-19-039 | Chen, Ken | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | First-year cost $398,399 | Study section ZCA1 |
| FY2020 | Informatics tools for identification, prioritization and clinical application of neoantigens1U01CA248235-01 · under RFA-CA-19-039 | Griffith, Malachi | WASHINGTON UNIVERSITY, MO | First-year cost $391,732 | Study section ZCA1 |
| FY2020 | RadxTools for assessing tumor treatment response on imaging1U01CA248226-01 · under RFA-CA-19-039 | Tiwari, PallaviViswanath, Satish Easwar | CASE WESTERN RESERVE UNIVERSITY, OH | First-year cost $383,017 | Study section ZCA1 |
| FY2020 | Technology for efficient simulation of cancer cell transport1U01CA253511-01 · under RFA-CA-19-039 | Randles, Amanda E | DUKE UNIVERSITY, NC | First-year cost $370,690 | Study section ZCA1 |
Newest fiscal year first, then first-year cost.
Patents from its funded projects
6 patents name 1 of the 23 funded projects. The newest 5, by patent number.
- US 12,755,841 (opens the patent at USPTO, a PDF, in a new tab)MULTI-SITE CROSS-ORGAN CALIBRATED DEEP LEARNING (MUSCID) METHOD AND APPARATUSGranted October 6, 2026 to Case Western Reserve University, Emory University and 2 othersU01CA248226 · CASE WESTERN RESERVE UNIVERSITY, OH
- US 12,530,770 (opens the patent at USPTO, a PDF, in a new tab)DEEP-LEARNING-BASED HEPATIC FAT ASSESSMENTGranted January 20, 2026 to Case Western Reserve University, Emory University and University Hospitals Cleveland Medical CenterU01CA248226 · CASE WESTERN RESERVE UNIVERSITY, OH
- US 12,400,327 (opens the patent at USPTO, a PDF, in a new tab)HYBRID CONVOLUTIONAL WAVELET NETWORKS FOR PREDICTING TREATMENT RESPONSE VIA RADIOLOGICAL IMAGES OF BOWEL DISEASEGranted August 26, 2025 to Case Western Reserve UniversityU01CA248226 · CASE WESTERN RESERVE UNIVERSITY, OH
- US 12,159,403 (opens the patent at USPTO, a PDF, in a new tab)COMBINATION OF FEATURES FROM BIOPSIES AND SCANS TO PREDICT PROGNOSIS IN SCLCGranted December 3, 2024 to The United States Government as Represented by the Department of Veteran AffairsU01CA248226 · CASE WESTERN RESERVE UNIVERSITY, OH
- US 12,073,560 (opens the patent at USPTO, a PDF, in a new tab)COMPUTATIONAL FEATURES OF TUMOR-INFILTRATING LYMPHOCYTE (TIL) ARCHITECTUREGranted August 27, 2024 to University of Pittsburgh—Of the Commonwealth System of Higher EducationU01CA248226 · CASE WESTERN RESERVE UNIVERSITY, OH
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-12-0.3.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.